What is Novastep?
Novastep International operates as a global entity dedicated to the design, development, and commercialization of advanced solutions for foot and ankle surgical procedures. Their portfolio includes specialized surgical instruments and implants, such as the PECA MIS Bunion Correction and the AIRLOCK Plating System, engineered to enhance surgical outcomes and patient recovery. The company primarily serves orthopedic surgeons and healthcare institutions, aiming to provide disruptive technologies that improve both surgical efficiency and the patient healing process.
How much funding has Novastep raised?
Novastep has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Novastep
PPP
Public-Private Partnership
What's next for Novastep?
With the recent influx of capital from a major strategic investment, Novastep is poised for accelerated growth and expansion. This large-scale, late-stage funding suggests a strategic focus on scaling operations, further research and development, and potentially broadening market penetration. The company's commitment to innovation in foot and ankle surgery positions it to capitalize on increasing demand for minimally invasive techniques and advanced orthopedic implants. Future developments are likely to center on enhancing their existing product lines and exploring new therapeutic areas within orthopedic care.
See full Novastep company page
